HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Homa Tajsharghi Selected Research

Multiple pterygium syndrome

3/2016Lethal multiple pterygium syndrome, the extreme end of the RYR1 spectrum.
1/2016Truncating CHRNG mutations associated with interfamilial variability of the severity of the Escobar variant of multiple pterygium syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Homa Tajsharghi Research Topics

Disease

20Muscular Diseases (Myopathy)
12/2020 - 02/2004
4Cardiomyopathies (Cardiomyopathy)
01/2021 - 05/2010
4Myosin Storage Myopathy
12/2020 - 01/2013
4Arthrogryposis
03/2016 - 08/2008
3Muscle Weakness
07/2015 - 06/2007
2Multiple pterygium syndrome
03/2016 - 01/2016
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2021
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
12/2020
1Aortic Valve Stenosis (Aortic Stenosis)
01/2020
1Hypertrophy
01/2020
1Vaccinia
11/2019
1Muscular Atrophy (Muscle Atrophy)
11/2019
1Intellectual Disability (Idiocy)
01/2019
1Polyneuropathies (Polyneuropathy)
01/2019
1Gait Ataxia
12/2018
1Apraxias (Dyspraxia)
12/2018
1Edema (Dropsy)
03/2016
1Pterygium
03/2016
1Cystic Lymphangioma (Hygroma)
03/2016
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
07/2015
1Ophthalmoplegia (External Ophthalmoplegia)
06/2014
1Distal Myopathies (Distal Muscular Dystrophy)
01/2013
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
12/2012
1Hereditary Myopathy with Early Respiratory Failure
06/2012
1Cardiac Arrhythmias (Arrythmia)
04/2010
1Congenital Abnormalities (Deformity)
06/2007

Drug/Important Bio-Agent (IBA)

11Myosins (Myosin)IBA
12/2020 - 02/2004
8Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2017 - 02/2004
7Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2008
5Protein Isoforms (Isoforms)IBA
01/2013 - 02/2004
4Cardiac MyosinsIBA
12/2020 - 08/2010
4Protein AggregatesIBA
01/2017 - 01/2013
3TropomyosinIBA
01/2013 - 06/2007
2Proteasome Endopeptidase Complex (Proteasome)IBA
12/2020 - 01/2020
2UbiquitinIBA
12/2020 - 01/2020
2Nonmuscle Myosin Type IIAIBA
06/2014 - 01/2013
1Myosin Light Chains (Myosin Essential Light Chain)IBA
01/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2020
1Ligases (Synthetase)IBA
01/2020
1Phosphotransferases (Kinase)IBA
11/2019
1Nuclear Proteins (Protein, Nuclear)IBA
01/2019
1Explosive Agents (Explosives)IBA
12/2018
1Tripartite Motif ProteinsIBA
10/2018
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
03/2016
1Cholinergic ReceptorsIBA
01/2016
1Mutant Proteins (Protein, Mutant)IBA
01/2015
1Myosin SubfragmentsIBA
01/2013
1ConnectinIBA
06/2012
1Carrier Proteins (Binding Protein)IBA
08/2010
1GlycogenIBA
04/2010
1Contractile ProteinsIBA
06/2008
1Selenoproteins (Selenoprotein)IBA
04/2005

Therapy/Procedure

1Endurance Training
02/2004